A rapidly growing malignant mesenchymal neoplasm. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma resembling an alveolar growth pattern. T...
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Documentation on alveolar rhabdomyosarcoma is limited due to its rarity and the complexities involved in its clinical characterization. The condition affects a small number of individuals, which restricts the scope of systematic clinical studies. Additionally, the genetic basis of ARMS has only recently been identified, and ongoing research aims to further elucidate its clinical features and treatment options.
To navigate your care effectively, consider seeking a pediatric oncologist with expertise in sarcomas, particularly those specializing in rhabdomyosarcoma. Genetic counseling may also be beneficial given the involvement of specific genes like FOXO1, PAX3, and PAX7. For additional support, you can explore resources such as the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov. Participation in clinical trials may provide access to cutting-edge treatments, so inquire about eligibility during your consultations.
Currently, there are 11 active clinical trials investigating various aspects of alveolar rhabdomyosarcoma. These trials may explore novel treatment options and therapeutic strategies. For more information on these trials, you can search at ClinicalTrials.gov using this link: https://clinicaltrials.gov/search?cond=alveolar%20rhabdomyosarcoma.
Actionable guidance for navigating care for alveolar rhabdomyosarcoma
To navigate your care effectively, consider seeking a pediatric oncologist with expertise in sarcomas, particularly those specializing in rhabdomyosarcoma. Genetic counseling may also be beneficial given the involvement of specific genes like FOXO1, PAX3, and PAX7. For additional support, you can explore resources such as the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov. Participation in clinical trials may provide access to cutting-edge treatments, so inquire about eligibility during your consultations.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease